Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-effectiveness study of nitrate therapy using a decision analysis methodology.

E P Larrat1

  • 1College of Pharmacy, University of Rhode Island, Kingston 02881.

Hospital Formulary
|April 1, 1994
PubMed
Summary

Isosorbide mononitrate (ISMO) offers a cost-effective treatment for stable angina compared to isosorbide dinitrate (ISDN) and nitroglycerin patches. ISMO demonstrates lower overall costs and improved patient management due to less titration and fewer side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient compliance and blood pressure control on a nuclear-powered aircraft carrier: impact of a pharmacy officer.

Military medicine·2000
Same author

Cocaine use and HIV disease progression among heterosexuals.

Pharmacoepidemiology and drug safety·1996
Same author

Screening for peripheral arterial disease.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1996
Same author

Regulatory environment and psychotropic use in board-and-care facilities: results of a 10-state study.

The journals of gerontology. Series A, Biological sciences and medical sciences·1996
Same author

Psychotropic use among older residents of board and care facilities.

Journal of the American Geriatrics Society·1995
Same author

Cocaine use and heterosexual exposure to human immunodeficiency virus.

Epidemiology (Cambridge, Mass.)·1994

Area of Science:

  • Pharmacoeconomics
  • Clinical Practice Research
  • Health Services Research

Background:

  • Angina treatment involves various nitrate therapies with differing economic profiles.
  • Decision analysis provides a framework for evaluating treatment costs and clinical utility.
  • Understanding the economic impact is crucial for healthcare decision-makers.

Purpose of the Study:

  • To assess the economic impact of isosorbide mononitrate (ISMO) versus isosorbide dinitrate (ISDN) and nitroglycerin patches for stable angina.
  • To demonstrate the utility of decision analysis in healthcare economic evaluations.
  • To inform physicians, administrators, and manufacturers about cost-effective angina management.

Main Methods:

  • Decision analysis cost-assessment technology was employed.

Related Experiment Videos

  • Comparative economic evaluation of ISMO, ISDN, and nitroglycerin patches.
  • Analysis focused on anticipated treatment costs in stable angina patients.

    • Main Results:

    • Isosorbide mononitrate (ISMO) showed lower total anticipated treatment costs than ISDN (28% reduction) and nitroglycerin patches (16% reduction).
    • Despite a higher unit cost, ISMO's overall economic advantage was demonstrated.
    • ISMO requires less dosing titration and is associated with fewer tolerance effects compared to ISDN and nitroglycerin patches.

    Conclusions:

    • Isosorbide mononitrate (ISMO) presents a more cost-effective therapeutic option for stable angina management.
    • Decision analysis is a valuable tool for evaluating the economic implications of new pharmaceutical therapies.
    • Healthcare stakeholders should consider both clinical efficacy and economic factors in treatment choices.